http://purl.uniprot.org/citations/29018006 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/29018006 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundHypertrophic cardiomyopathy is the most common type of cardiomyopathy, but many patients lack sarcomeric/myofilament mutations. We studied whether cardio-specific α-galactosidase A gene variants are misinterpreted as hypertrophic cardiomyopathy because of the lack of extracardiac organ involvement.Methods and resultsAll subjects who tested positive for the N215S genotype (n=26, 13 females, mean age 49±17 [range, 14-74] years) were characterized in this prospective monocentric longitudinal cohort study to determine genotype-specific clinical characteristics of the N215S (c.644A>G [p.Asn215Ser]) α-galactosidase A gene variant. All subjects were initially referred with suspicion of genetically determined hypertrophic cardiomyopathy. Cardiac hypertrophy (interventricular septum, 12±4 [7-23] mm; left ventricular posterior wall, 11±4 [7-21] mm; left ventricular mass, 86±41 [46-195] g/m2) was progressive, systolic function mainly preserved (cardiac index 2.8±0.6 [1.9-3.9] L/min per m2), and diastolic function mildly abnormal. Cardiac magnetic resonance imaging revealed replacement fibrosis in loco typico (18/26, 69%), particularly in subjects >50 years. Elderly subjects had advanced heart failure, and 6 (23%) were suggested for implantable cardioverter-defibrillator therapy. Leukocyte α-galactosidase A enzyme activity was mildly reduced in 19 subjects and lyso-globotriaosylceramide slightly elevated (median, 4.9; interquartile range, 1.3-9.1 ng/mL). Neurological and renal impairments (serum creatinine, 0.87±0.20; median, 0.80; interquartile range, 0.70-1.01 mg/dL; glomerular filtration rate, 102±23; median, 106; interquartile range, 84-113 mL/min) were discreet. Only 2 subjects developed clinically relevant proteinuria.Conclusionsα-Galactosidase A genotype N215S does not lead to the development of a classical Fabry phenotype but induces a specific cardiac variant of Fabry disease mimicking nonobstructive hypertrophic cardiomyopathy. The lack of prominent noncardiac impairment leads to a significant delay in diagnosis and Fabry-specific therapy."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.org/dc/terms/identifier | "doi:10.1161/circgenetics.116.001691"xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Hu K."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Liu D."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Wanner C."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Grone H.J."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Kandolf R."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Lorenz K."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Sommer C."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Ertl G."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Nordbeck P."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Uceyler N."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Oder D."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Muntze J."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/author | "Salinger T."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/date | "2017"xsd:gYear |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/name | "Circ Cardiovasc Genet"xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/pages | "e001691"xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/title | "alpha-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease."xsd:string |
http://purl.uniprot.org/citations/29018006 | http://purl.uniprot.org/core/volume | "10"xsd:string |
http://purl.uniprot.org/citations/29018006 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/29018006 |
http://purl.uniprot.org/citations/29018006 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/29018006 |
http://purl.uniprot.org/uniprot/#_A0A0S3Q2A7-mappedCitation-29018006 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29018006 |
http://purl.uniprot.org/uniprot/#_B4DLT5-mappedCitation-29018006 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/29018006 |